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Abstract
Introduction: Evidence on perinatal mental health during the coronavirus disease 
2019 (COVID- 19) pandemic and its potential determinants is limited. Therefore, this 
multinational study aimed to assess the mental health status of pregnant and breast-
feeding women during the pandemic, and to explore potential associations between 
depressive symptoms, anxiety, and stress and women's sociodemographic, health, 
and reproductive characteristics.
Material and methods: A cross- sectional, web- based study was performed in Ireland, 
Norway, Switzerland, the Netherlands, and the UK between 16 June and 14 July 
2020. Pregnant and breastfeeding women up to 3 months postpartum who were 
older than 18 years of age were eligible. The online, anonymous survey was promoted 
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1  |  INTRODUC TION
Since December 2019, the new coronavirus severe acute respira-
tory syndrome coronavirus 2 (SARS- CoV- 2), which causes coronavi-
rus disease 2019 (COVID- 19), has spread worldwide. To slow down 
the transmission of the virus and effectively control the pandemic, 
exceptional and unprecedented measures were taken by policy- 
makers across countries, such as the closure of workplaces, schools, 
shops, recreational facilities, bars, and restaurants.1 These public 
health measures restricted individuals’ liberty and affected every 
part of society.2
The potential impact of the COVID- 19 pandemic on mental 
health should not be neglected, especially in vulnerable popula-
tions.3,4 Pregnant and breastfeeding women are facing numerous 
life changes that make them particularly vulnerable to mental health 
disorders. According to the World Health Organization, about 10% 
of pregnant women and 13% of (recent) mothers experience a men-
tal disorder, primarily depression.5 A large multinational study on 
perinatal mental health conducted before the COVID- 19 era showed 
that between 4% and 8% of women have moderate- to- very severe 
depressive symptoms during pregnancy and in the postnatal pe-
riod.6 In the context of the COVID- 19 pandemic, maternal distress 
might be compounded by concerns and fears regarding the risk of 
infection or hospitalization due to COVID- 19, especially as perina-
tal morbidity and mortality associated with COVID- 19 have been 
described.7- 9 Maternal depressive symptoms, anxiety, and stress 
have been associated with adverse pregnancy, fetal, and (long- term) 
infant outcomes.10- 12 Therefore, it is critical that mental health disor-
ders are detected and addressed in clinical practice.
The extent to which pregnant and breastfeeding women have 
been emotionally affected by the pandemic remains under- explored. 
Previous publications have observed an increased likelihood of de-
pressive symptoms and anxiety among pregnant and postpartum/
breastfeeding cohorts during the early stages of the pandemic.13- 15 
However, these studies were limited by relatively small sample sizes 
and/or individual settings or countries. This highlights the need for 
larger, multinational studies. In addition, it remains unclear which 
women are at risk of being emotionally affected. Identifying determi-
nants associated with an increased risk of or protection from mental 
distress is vital to guide the development of effective prevention and 
intervention strategies. Therefore, the aim of this study was to as-
sess the mental health status of pregnant and breastfeeding women 
living in several countries across Europe during the pandemic, and to 
through social media and hospital websites. The Edinburgh Depression Scale (EDS), 
the Generalized Anxiety Disorder seven- item scale (GAD- 7), and the Perceived Stress 
Scale (PSS) were used to assess mental health status. Regression model analysis was 
used to identify factors associated with poor mental health status.
Results: In total, 9041 women participated (including 3907 pregnant and 5134 breast-
feeding women). The prevalence of major depressive symptoms (EDS ≥ 13) was 15% 
in the pregnancy cohort and and 13% the breastfeeding cohort. Moderate to severe 
generalized anxiety symptoms (GAD ≥ 10) were found among 11% and 10% of the 
pregnant and breastfeeding women. The mean (±SD) PSS scores for pregnant and 
breastfeeding women were 14.1 ± 6.6 and 13.7 ± 6.6, respectively. Risk factors as-
sociated with poor mental health included having a chronic mental illness, a chronic 
somatic illness in the postpartum period, smoking, having an unplanned pregnancy, 
professional status, and living in the UK or Ireland.
Conclusions: This multinational study found high levels of depressive symptoms and 
generalized anxiety among pregnant and breastfeeding women during the COVID- 19 
outbreak. The study findings underline the importance of monitoring perinatal mental 
health during pandemics and other societal crises to safeguard maternal and infant 
mental health.
K E Y W O R D S
anxiety, breastfeeding, coronavirus, COVID- 19, depression, pregnancy, SARS- CoV- 2, stress
Key message
Depressive and anxiety symptoms were often observed 
among pregnant and breastfeeding women during the 
COVID- 19 pandemic. Poor mental health status was asso-
ciated with a chronic mental or somatic illness, smoking, an 
unplanned pregnancy, professional status, and living in the 
UK or Ireland.
    |  3CEULEMANS Et AL.
explore potential associations between depressive symptoms, anx-
iety, and stress, and women’s sociodemographic, health, and repro-
ductive characteristics.
2  |  MATERIAL AND METHODS
A multinational, cross- sectional, web- based study was performed 
in Ireland, Norway, Switzerland, the Netherlands, and the UK 
between 16 June and 14 July 2020. Pregnant and breastfeeding 
women up to 3 months postpartum who were older than 18 years 
were eligible to participate. Data were collected through an anony-
mous online survey. The survey was promoted using banners on 
(hospital) websites, social media accounts, and pregnancy and 
breastfeeding forums commonly visited by pregnant women and/
or new mothers. Information about recruitment tools used and 
internet penetration rates is summarized in the Supplementary 
material (Table S1). The study findings are reported according to 
STROBE guidelines.
The survey was part of a large, multinational COVID- 19 research 
project aimed at studying pregnant and breastfeeding women’s 
mental health status, medication use, breastfeeding practices, ac-
cess to health services, and information needs during the pandemic. 
This manuscript focuses on women’s mental health status (see 
Supplementary material, Figure S1).
The Edinburgh Depression Scale (EDS), the Generalized Anxiety 
Disorder seven- item scale (GAD- 7), and the Perceived Stress Scale 
(PSS) were used to assess mental health status. Depressive symp-
toms were measured by the EDS, which is a self- report 10- item 
scale.16,17 Each question has four different options which are scored 
0, 1, 2, or 3. The scale rates the intensity of depressive symptoms 
over the last 7 days. Total score ranges between 0 and 30; major de-
pressive symptoms were defined as women having a total EDS score 
of ≥13, while ≥5 on the EDS anxiety subscale (EDS- 3A) was consid-
ered as high risk for anxiety.16,18,19 The GAD- 7 is a self- report scale 
that assesses the level of generalized anxiety experienced over the 
previous 2 weeks.20 The scale consists of seven items measuring 
the frequency of being bothered by specific problems on a four- 
point Likert scale ranging from not at all, several days, more than 
half of the days, and nearly every day (scored from 0 to 3). Total 
scores range between 0 and 21 with higher scores indicating more 
generalized anxiety. Total GAD- 7 scores were categorized into min-
imal (0- 4), mild (5- 9), moderate (10- 14), and severe (15- 21) anxiety. 
The PSS is a self- report scale of 10 items measuring the degree to 
which people perceive their lives as stressful.21- 23 Respondents are 
asked how often they have found their lives “unpredictable, uncon-
trollable, and overloaded” in the last month. The 10 items are as-
sessed on a five- point Likert scale with response categories never, 
almost never, sometimes, fairly often, and very often (scored from 
0 to 4). Total scores range between 0 and 40, with higher scores 
indicating larger perceived stress. The three mental health scales 
were available in all survey languages. The other questions were 
translated from English by the co- authors, including some open 
questions exploring the impact of SARS- CoV- 2 on women’s expe-
riences and lives.
Information on sociodemographic characteristics was collected 
through the survey, including country, maternal age, relationship 
status, professional status, highest education level, smoking in preg-
nancy, and breastfeeding. Highest completed educational level was 
categorized into low, medium, and high according to national defi-
nitions. Information on health and reproductive characteristics was 
also collected, including having received a test for SARS- CoV- 2 and 
the test result, chronic somatic and mental illness, parity, planned 
pregnancy, gestational trimester, pregnancy follow up, breastfeed-
ing duration, and previous breastfeeding experience. All women who 
completed the breastfeeding survey, including those who recently 
ceased breastfeeding, were grouped into the category “breastfeed-
ing women”. A chronic illness was considered a condition that al-
ready existed before pregnancy. Depression, anxiety disorders, and 
bipolar disorder were grouped into chronic mental illness.
2.1  |  Statistical analyses
Women’s characteristics and scores on the mental health measures 
were analyzed using descriptive statistics. Associations between de-
pressive symptoms (EDS ≥ 13) and characteristics of pregnant and 
breastfeeding women were estimated by univariable and multivari-
able logistic regression, and presented as crude (cOR) and adjusted 
(aOR) odds ratios and 95% CI. Associations between anxiety (GAD- 
7) and stress (PSS) were estimated by univariable and multivariable 
linear regression, and presented as unstandardized (B) regression co-
efficients and 95% CI. Logarithmic transformation of the dependent 
variable anxiety was performed to meet the required assumptions 
of linear regression; results of the latter regressions are presented 
on the natural logarithmic scale. All sociodemographic, health, and 
reproductive characteristics were entered as categorical variables 
in the models. Only significant covariates were retained in the final 
adjusted model, such as country, maternal age, professional status, 
smoking, chronic somatic and mental illness, planned pregnancy, and 
breastfeeding at the time of survey completion. Multicollinearity of 
the covariates included in the adjusted models was checked. Due 
to a technical error, item 7 of the EDS was lacking in the Norwegian 
survey. The EDS sum score for Norway was therefore calculated by 
multiple imputation. All statistical analyses were performed with the 
Statistical Package for the Social Sciences (SPSS) version 26 (IBM® 
SPSS® Statistics).
2.2  |  Ethical approval
Online informed consent was obtained from all participants before 
survey initiation. Ethical approval was waived in most countries, 
except for Ireland (Rotunda Hospital Research Ethics Committee, 
REC- 2020- 017, 23 June 2020). All data were stored and handled 
anonymously.
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3  |  RESULTS
3.1  |  Characteristics of the study participants
In total, 9041 women participated in the survey (ie, 3907 pregnant 
and 5134 breastfeeding women) (see Table 1). Most responses 
were collected from Norway (31%) and the Netherlands (29%), 
followed by Switzerland (19%), Ireland (18%), and the UK (3%). 
Overall, 91% of the postpartum women were still breastfeeding 
at the time of survey completion. A chronic somatic or mental ill-
ness was reported by 19% and 2% of the pregnant women, and 
by 16% and 1% of the breastfeeding women, respectively. Allergy 
(5%), asthma (5%), and depression (1%) were the most com-
monly reported chronic somatic and mental illnesses in the study 
population. About 10% of the respondents had been tested for 
SARS- CoV- 2. Of those, 7% (n = 23) of the pregnant women and 
6% (n = 33) of the breastfeeding women tested positive, corre-
sponding to a prevalence of confirmed COVID- 19 of <1% in this 
cohort. A comparison of participant characteristics with national 
TA B L E  1  Study characteristics of the women participating in the 
survey (n = 9041)
Pregnant women 
(n = 3907), % (n)
Breastfeeding 
women 




Ireland 17.7 (692) 17.8 (912)
Norway 34.4 (1344) 28.9 (1485)
Switzerland 14.4 (563) 23.2 (1193)
The Netherlands 30.0 (1173) 28.2 (1447)
United Kingdom 3.5 (135) 1.9 (97)
Maternal age (y)
18- 25 8.5 (274) 4.0 (164)
26- 30 33.1 (1069) 25.8 (1062)
31- 35 40.0 (1290) 45.4 (1864)
36- 40 16.5 (532) 20.9 (858)
>40 2.0 (64) 3.9 (161)
Relationship status
Partner 98.4 (3195) 98.5 (4076)
No partner 1.6 (51) 1.5 (62)
Professional status
Professionally active 90.5 (2881) 88.7 (3616)
Not professionally 
active
9.5 (302) 11.3 (461)
Highest education level
Low 5.6 (176) 7.3 (292)
Medium 25.6 (808) 24.7 (984)
High 68.8 (2168) 68.0 (2713)
Smoking in pregnancy/breastfeeding
Yes 2.6 (85) 3.4 (140)
No 97.4 (3161) 96.6 (3998)
Health and reproductive characteristics
SARS- CoV- 2
Tested 8.8 (332) 10.9 (520)
Tested positive 0.6 (23) 0.7 (33)
Chronic somatic illnessa 
Yes 18.6 (602) 15.8 (653)
No 81.4 (2643) 84.2 (3483)
Chronic mental illnessb 
Yes 2.2 (70) 1.1 (46)
No 97.8 (3175) 98.9 (4092)
Parity
Nulliparous 53.8 (2090) N/A
Multiparous 46.2 (1796) N/A
Planned pregnancy
Yes 80.0 (3127) N/A
(Continues)
Pregnant women 
(n = 3907), % (n)
Breastfeeding 
women 
(n = 5134), 
% (n)
No 6.7 (262) N/A













Pregnancy follow- up mainly by
Obstetrician 29.3 (1099) N/A
Midwife 53.7 (2015) N/A
General practitioner 14.9 (560) N/A
Specialist 2.2 (81) N/A
Current breastfeeding duration
≤6 wk N/A 15.8 (741)
Between 6 wk and 
6 mo
N/A 48.2 (2257)
>6 mo N/A 36.0 (1685)
Previous breastfeeding experience
Yes N/A 55.7 (2797)
No N/A 44.3 (2221)
Note: Numbers may not add up due to missing values.
Abbreviations N/A, question was not applicable.
aRefers to nonmental illnesses. 
bRefers to depression, anxiety disorders, and bipolar disorder. 
TABLE 1 (Continued)
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birthing population data is included in the Supplementary material 
(Table S2).
3.2  |  Mental health status of the pregnant and 
breastfeeding women
The observed prevalence of major depressive symptoms (EDS ≥ 13) 
was 15% and 13% in the pregnancy and breastfeeding cohorts, 
respectively. Moderate to severe generalized anxiety symptoms 
(GAD- 7 ≥ 10) were found among 11% and 10% of the pregnant and 
breastfeeding women, respectively. The mean ± SD) PSS scores for 
pregnant and breastfeeding women were 14.1 ± 6.6 and 13.7 ± 6.6, 
respectively. The findings for major depressive symptoms, general-
ized anxiety, and stress were worse among women residing in the 
UK and Ireland (see Table 2). A visual representation of the distri-
bution of the scale scores is included in the Supplementary material 
(Figures S2- S4). Illustrative responses to the open- ended questions 
are presented in the Supplementary material (Table S3). Women 
answered, for example, that their partners were often not allowed 
during prenatal visits, at the delivery and/or during the postna-
tal period in the hospital during the pandemic, and that they had 
fear of the impact of COVID- 19 on the unborn child and their own 
health.
TA B L E  2  Mental health status of pregnant and breastfeeding women during the COVID- 19 pandemic
Pregnant women Breastfeeding women
N % Mean (SD) N %
Mean 
(SD)
EDS General 3545 100.0 7.1 (5.1) 4542 100.0 7.4 (4.6)
Score ≥10 1006 28.4 N/A) 1287 28.3 N/A
Score ≥13 533 15.0 N/A 592 13.1 N/A
Country
United Kingdom (≥13) 48 42.1 N/A 33 42.3 N/A
Ireland (≥13) 158 26.3 N/A 186 24.3 N/A
Norway (≥13) 161 12.0 N/A 217 14.6 N/A
The Netherlands (≥13) 115 11.5 N/A 113 9.1 N/A
Switzerland (≥13) 51 10.5 N/A 102 10.4 N/A
EDS- 3A Score ≥5 1749 49.3 5.8 (0.9) 1749 38.5 5.8 (0.9)
GAD- 7 Total 3467 100.0 4.8 (4.1) 4455 100.0 4.4 (4.0)
Minimal (0- 4) 1860 53.6 N/A 2594 58.2 N/A
Mild (5- 9) 1235 35.6 N/A 1492 32.1 N/A
Moderate (10- 14) 248 7.2 N/A 296 6.6 N/A
Severe (15- 21) 124 3.6 N/A 136 3.1 N/A
Country
United Kingdom (10- 21) 31 28.2 N/A 18 23.7 N/A
Ireland (10- 21) 87 14.7 N/A 124 16.5 N/A
Norway (10- 21) 166 12.4 N/A 156 10.5 N/A
The Netherlands (10- 21) 61 6.4 N/A 57 4.8 N/A
Switzerland (10- 21) 27 5.8 N/A 77 8.1 N/A
PSS General 3347 100.0 14.1 (6.6) 4295 100.0 13.7 (6.6)
Country
United Kingdom 108 3.2 19.5 (7.5) 72 1.7 19.6 (7.5)
Ireland 567 16.9 16.4 (6.9) 726 16.9 16.6 (6.6)
Switzerland 440 13.1 14.2 (5.5) 891 20.7 14.6 (6.4)
Norway 1344 40.2 13.7 (6.3) 1485 34.6 12.8 (6.3)
The Netherlands 888 26.5 12.4 (6.3) 1121 26.1 12.1 (6.1)
Note: Due to a technical error, item 7 of the EDS was lacking in the Norwegian survey. The EDS sum score for Norway was therefore calculated by 
multiple imputation.
Abbreviations: EDS, Edinburgh Depression Scale (16); EDS- 3A, Edinburgh Depression Anxiety Subscale; GAD- 7, Generalized Anxiety Disorder Seven- 
item Scale (20); N/A, not applicable; PSS, Perceived Stress Scale (21).
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3.3  |  Factors associated with mental health 
status of pregnant and breastfeeding women
Overall, a higher likelihood of major depressive symptoms (EDS ≥ 13) 
was observed among pregnant and breastfeeding women who re-
ported a chronic mental illness, smoking, and living in the UK or 
Ireland. Major depressive symptoms were also associated with no 
breastfeeding at the time of survey completion, having an unplanned 
pregnancy, and having a chronic somatic illness in the postpartum 
period (see Table 3).
Generalized anxiety among pregnant and breastfeeding women 
was positively associated with having a chronic mental illness and 
negatively associated with being professionally active in health care 
(see Table 4). Anxiety symptoms were also more likely among preg-
nant women living in the UK, smoking in pregnancy, and having an 
unplanned pregnancy, as well as among unemployed breastfeeding 
women and women suffering from a chronic somatic illness in the 
postpartum period.
Stress among pregnant and breastfeeding women was positively 
associated with having a chronic mental illness, having a chronic so-
matic illness, and living in the UK or Ireland (see Table 5). Likewise, 
stress symptoms were more likely among women smoking in preg-
nancy and having an unplanned pregnancy, as well as among breast-
feeding women who reported being unemployed and women who 
were no longer breastfeeding when completing the survey. Stress 
among pregnant women decreased with increasing age.
With regard to COVID- 19, pregnant and breastfeeding women 
who had tested positive for SARS- CoV- 2 were not more likely to have 
major depressive symptoms, generalized anxiety, or stress at the time 
of survey completion compared with women without a positive test 
result. Reproductive characteristics such as parity and gestational tri-
mester were also not associated with women's mental health status.
4  |  DISCUSSION
This cross- sectional, web- based study aimed to assess the mental 
health status of pregnant and breastfeeding women faced with an 
unprecedented pandemic, and to identify factors associated with 
mental health status. To our knowledge, this is the first multinational 
study across several European countries using a broad range of in-
ternationally recognized mental health measures and uniform data 
TA B L E  3  Factors associated with major depressive symptoms (EDS ≥ 13) among pregnant and breastfeeding women
Pregnant women Breastfeeding women
cOR 95% CI aORa  95% CI cOR 95% CI aORb  95% CI
Country
Norway Ref Ref Ref Ref Ref Ref Ref Ref
Ireland 2.63 2.06- 3.36 2.55 1.97- 3.31 2.64 2.08- 3.34 2.70 2.10- 3.46
Switzerland 0.86 0.62- 1.20 0.82 0.57- 1.19 0.95 0.73- 1.24 1.03 0.77- 1.37
The Netherlands 0.96 0.74- 1.23 0.85 0.78- 1.36 0.83 0.64- 1.07 0.90 0.69- 1.18
United Kingdom 5.34 3.56- 8.03 4.64 2.96- 7.26 6.02 3.72- 9.72 5.78 3.45- 9.68
Professional status
Active, but not in health care Ref Ref Ref Ref Ref Ref — — 
Active in health care 0.77 0.61- 0.97 0.80 0.63- 1.01 0.90 0.73- 1.11 — — 
Not professionally active 1.87 1.40- 2.50 1.35 0.98- 1.85 1.32 0.99- 1.74 — — 
Smoking in pregnancy/breastfeeding
Yes 2.47 1.53- 3.97 2.12 1.26- 3.56 1.86 1.23- 2.81 1.72 1.10- 2.67
Chronic somatic illness
Yes 1.20 0.95- 1.53 — — 1.59 1.27- 1.99 1.51 1.18- 1.92
Chronic mental illness
Yes 5.43 3.36- 8.77 4.35 2.55- 7.41 6.88 3.83- 12.35 5.76 3.09- 10.74
Planned pregnancy
No 2.11 1.54- 2.89 1.65 1.15- 2.38 N/A N/A N/A N/A
No, but it was not unexpected 1.74 1.36- 2.23 1.60 1.21- 2.10 N/A N/A N/A N/A
Breastfeeding at the time of survey completion
No N/A N/A N/A N/A 1.85 1.42- 2.42 1.69 1.26- 2.27
Note: The bold numbers indicate adjusted odds ratios where the 95% confidence interval does not include 1.
Abbreviations: CI, confidence interval, cOR, crude odds ratio, aOR, adjusted odds ratio; N/A, not available.
aAdjusted for country, professional status, smoking in pregnancy, chronic mental illness, and planned pregnancy. 
bAdjusted for country, smoking in breastfeeding, chronic somatic and mental illness, and breastfeeding at the time of survey completion. 
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collection among pregnant and breastfeeding women. Moreover, 
the “women’s voices” included in this study through the open- ended 
quotations shed important light on the mental health challenges 
these women face in their everyday lives.
The survey was distributed in June- July 2020, beyond the peak 
of the first wave of the pandemic in all study countries (except for 
the UK), at a time when the strictest containment measures had 
been lifted (except for the UK and Ireland). The overall prevalence 
of major depressive symptoms was about 14%, with higher scores 
observed among women living in the UK and Ireland. The over-
all percentage is somewhat higher than the prevalence estimates 
reported among pregnant and postpartum women living in high- 
income countries before COVID- 19 (10%- 13%),5,24 but substantially 
lower than estimates observed in other countries during the early 
stages of the pandemic when strict containment measures were in 
place (24%- 37%).14,18 As postnatal depression is often a continua-
tion of symptoms that already manifested during pregnancy,25 these 
findings should encourage detection and appropriate management 
of mental distress in clinical practice. With regard to generalized 
anxiety, a similar pattern was found, with a slightly higher preva-
lence (10%- 11%) compared with the non- COVID- 19 era (2%- 9%),26 
but lower than rates reported in Belgium during severe restrictions 
TA B L E  4  Factors associated with generalized anxiety (GAD- 7) among pregnant and breastfeeding women
Pregnant women Breastfeeding women
Crude Adjusteda  Crude Adjustedb 
B 95% CI B 95% CI B 95% CI B 95% CI
Country
Norway Ref Ref Ref Ref Ref Ref Ref Ref
Ireland −0.00 −0.07 to 0.07 0.02 −0.05 to 0.10 0.01 −0.06 to 0.08 0.07 −0.01 to 0.14
Switzerland −0.24 −0.32 to −0.16 −0.21 −0.30 to −0.13 −0.21 −0.28 to −0.15 −0.15 −0.22 to −0.08
The Netherlands −0.42 −0.48 to −0.36 −0.39 −0.45 to −0.32 −0.43 −0.49 to −0.37 −0.40 −0.46 to −0.34
United Kingdom 0.31 0.16- 0.45 0.29 0.13- 0.44 0.20 0.02- 0.38 0.17 −0.02 to 0.36
Maternal age (y)
18- 25 0.27 0.17- 0.37 0.19 0.09- 0.29 0.21 0.09- 0.34 0.07 −0.05 to 0.20
26- 30 0.03 −0.03 to 0.09 0.03 −0.04 to 0.09 0.05 −0.02 to 0.11 0.04 −0.02 to 0.10
31- 35 Ref Ref Ref Ref Ref Ref Ref Ref
36- 40 −0.01 −0.09 to 0.06 −0.03 −0.11 to 0.04 −0.03 −0.10 to 0.03 −0.08 −0.14 to −0.02
>40 −0.03 −0.23 to 0.16 −0.15 −0.34 to 0.04 −0.02 −0.15 to 0.11 −0.10 −0.23 to 0.02
Professional status
Active, but not in health 
care
Ref Ref Ref Ref Ref Ref Ref Ref
Active in health care −0.10 −0.16 to −0.04 −0.08 −0.14 to −0.02 −0.10 −0.16 to −0.05 −0.07 −0.13 to −0.02
Not professionally active 0.16 0.07- 0.26 0.02 −0.08 to 0.11 0.14 0.06- 0.22 0.10 0.02- 0.18
Smoking in pregnancy/breastfeeding
Yes 0.21 0.04- 0.38 0.21 0.04- 0.37 0.12 −0.01 to 0.25 — — 
Chronic somatic illness
Yes 0.15 0.08- 0.22 0.06 −0.01 to 0.13 0.21 0.15- 0.28 0.15 0.09- 0.22
Chronic mental illness
Yes 0.78 0.60- 0.96 0.59 0.40- 0.78 0.77 0.54- 1.00 0.58 0.35- 0.81
Planned pregnancy
No 0.26 0.16- 0.37 0.17 0.07- 0.28 N/A N/A N/A N/A
No, but it was not 
unexpected
0.19 0.11- 0.26 0.10 0.03- 0.18 N/A N/A N/A N/A
Breastfeeding at the time of survey completion
No N/A N/A N/A N/A 0.09 0.01- 0.18 0.09 −0.00 to 0.17
Note: The results were obtained after natural logarithmic transformation of the dependent variable and are presented on this scale. The bold 
numbers indicate the 95% CI of the unstandardized regression coefficients of the adjusted analyses that do not include the null.
Abbreviations: B, unstandardized regression coefficient; CI, confidence interval; N/A, not available.
aAdjusted for country, maternal age, professional status, smoking in pregnancy, chronic somatic and mental illness, and planned pregnancy. 
bAdjusted for country, maternal age, professional status, chronic somatic and mental illness, and breastfeeding at the time of survey completion. 
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(14%).14 This finding is in line with a recent Chinese study suggesting 
that prenatal anxiety increases with the severity of the measures 
imposed.13 As illustrated by the respondents’ quotations, partners 
were often not allowed to attend perinatal checks and the delivery. 
As shown previously, women described considerable psychological 
suffering due to the exclusion of their partners from antenatal visits 
and around the time of birth.27 A recent review concluded that a 
lack of social and/or partner support is a risk factor for antenatal de-
pression,28 so future policy decisions should carefully consider the 
impact of infection- reducing measures on the supporting role of the 
partner in the perinatal period.
As poor mental health can lead to adverse maternal and in-
fant outcomes, insight into potential influencing factors is critical. 
Identified risk factors associated with poor mental health included: 
a chronic mental illness, a somatic illness in the postpartum period, 
smoking, an unplanned pregnancy, professional status, and living in 
the UK or Ireland. Having a chronic physical condition has previously 
been identified as a risk factor for perinatal mental illness.29 Limited 
TA B L E  5  Factors associated with perceived stress (PSS) among pregnant and breastfeeding women
Pregnant women Breastfeeding women
Crude Adjusteda  Crude Adjustedb 
B 95% CI B 95% CI B 95% CI B 95% CI
Country
Norway Ref Ref Ref Ref Ref Ref Ref Ref
Ireland 2.72 2.10- 3.35 3.04 2.38- 3.69 3.87 3.30- 4.43 4.17 3.58- 4.76
Switzerland 0.56 −0.13 to 1.24 0.99 0.29- 1.70 1.80 1.27- 2.32 1.87 1.32- 2.42
The Netherlands −1.23 −1.77 to 
−0.69
−0.93 −1.48 to −0.38 −0.72 −1.21 to 
−0.23
−0.48 −0.99 to 
0.02
United Kingdom 5.84 4.59- 7.08 5.53 4.23- 6.83 6.82 5.32- 8.32 6.40 4.88- 7.92
Maternal age (y)
18- 25 2.08 1.23- 2.94 1.63 0.77- 2.50 0.87 −0.18 to 1.92 0.74 −0.30- 1.77
26- 30 0.18 −0.35- 0.72 0.54 0.03- 1.06 −0.19 −0.68 to 0.31 0.31 −0.17 to 0.79
31- 35 Ref Ref Ref Ref Ref Ref Ref Ref
36- 40 0.37 −0.29 to 1.04 −0.20 −0.83 to 0.44 0.77 0.24- 1.30 0.17 −0.35 to 
0.68
>40 −0.35 −2.00 to 1.29 −1.93 −3.52 to −0.33 0.98 −0.08 to 2.04 −0.14 −1.16 to 0.88
Professional status
Active, but not in health care Ref Ref Ref Ref Ref Ref Ref Ref
Active in health care −0.92 −1.42 to 
−0.42
−0.83 −1.31 to −0.35 −0.54 −0.99 to 
−0.08
−0.40 −0.83 to 
0.04
Not professionally active 2.00 1.21- 2.80 0.53 −0.27 to 1.33 1.70 1.05- 2.35 1.22 0.58- 1.85
Smoking in pregnancy/breastfeeding
Yes 2.70 1.28- 4.11 1.59 0.20- 2.98 1.73 0.63- 2.84 0.89 −0.19 to 1.97
Chronic somatic illness
Yes 1.15 0.57- 1.73 0.68 0.11- 1.26 1.34 0.79- 1.89 1.17 0.62- 1.71
Chronic mental illness
Yes 7.90 6.36- 9.43 6.37 4.79- 7.95 7.99 6.09- 9.88 7.00 5.10- 8.89
Planned pregnancy
No 3.20 2.32- 4.08 2.31 1.40- 3.21 N/A N/A N/A N/A
No, but it was not unexpected 1.65 1.00- 2.30 1.05 0.40- 1.71 N/A N/A N/A N/A
Breastfeeding at the time of survey completion
No N/A N/A N/A N/A 1.19 0.47- 1.91 0.81 0.10- 1.52
Note: The bold numbers indicate the 95% CI of the unstandardized regression coefficients of the adjusted analyses that do not include the null.
Abbreviations: B, unstandardized regression coefficient; CI, confidence interval; N/A, not available.
aAdjusted for country, maternal age, professional status, smoking in pregnancy, chronic somatic and mental illness, and planned pregnancy. 
bAdjusted for country, maternal age, professional status, smoking in breastfeeding, chronic somatic and mental illness, and breastfeeding at the time 
of survey completion. 
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access to health services during the pandemic may have prevented 
women with chronic illnesses from seeing clinicians, potentially con-
tributing to an increased psychological burden.30,31 Professional sta-
tus also appeared to have an impact on anxiety and stress levels. 
While working in health care may have protected women to some 
extent, being unemployed placed women at higher risk of experi-
encing mental distress. As the first wave of the pandemic was al-
most over in most countries at the time of study completion, this 
might have led to some careful optimism, reduced workload, or 
(slightly) more pleasant working conditions among healthcare pro-
fessionals. Healthcare personnel might also be the best informed 
about COVID- 19 and pregnancy or lactation. In contrast, given the 
high rates of job losses and substantial job insecurity associated 
with the ongoing health crisis,2 clinicians should be vigilant for the 
emotional well- being of the growing group of unemployed women. 
Furthermore, women living in the UK and Ireland were more likely to 
report higher levels of mental distress. This may be explained by the 
fact that the social distancing restrictions were still in place in the 
UK and had only recently eased in Ireland at the time of the study 
(see Supplementary material, Table S4).32 These findings contribute 
to the growing evidence of the potential deleterious effect of strict 
lockdown measures on women's mental health.13,14 Interestingly, 
a UK cohort study performed in April 2020 observed the largest 
increase in mental distress under the conditions of the pandemic 
among women aged 18- 34 years and living with young children, 
which is reflective of our study population.4 On the other hand, a 
higher prevalence of perinatal depressive symptoms among UK res-
idents, compared with their Norwegian counterparts, was already 
previously reported before the COVID- 19 outbreak.6
Although only a few women with confirmed COVID- 19 were en-
rolled, no association was found between a positive test result and 
mental health status. It should be acknowledged, however, that the 
EDS and GAD- 7 only collect information on depressive symptoms 
and anxiety experienced over the last 1- 2 weeks.16,21 As data on the 
exact timing of the infection were unavailable, it is possible that the 
positive test occurred weeks or months ago and that mental distress 
had already improved or resolved.
The study was performed in collaboration with several mem-
bers of the European Network of Teratology Information Services. 
The multinational approach resulted in a large sample of over 9000 
women living across Europe, allowing a comparison between coun-
tries. To maximize data uniformity, the same data collection instru-
ment consisting of validated scales commonly used in the perinatal 
setting was used across all countries, which is a clear advantage over 
previous smaller and single- country studies. Healthcare profession-
als will in turn benefit from the insight generated by the quotations 
on women's personal experiences during the pandemic.
Some limitations should also be considered. First, the survey was 
promoted through social media, a sampling technique with an inher-
ent risk of selection (sampling) bias. However, web- based studies 
have been considered a reasonable recruitment method for epide-
miological studies, and the internet penetration rate is high among 
European women of childbearing age.33,34 Compared with national 
birthing population data, participants were more often first- time 
mothers, more highly educated, professionally active and nonsmok-
ers, and more often had a partner. This might indicate a selection 
bias toward more healthy study participants. As women with higher 
education attainment and with a partner tend to have fewer ante-
natal depressive symptoms and anxiety,35,36 the high prevalence 
observed in our sample might reflect the impact of the pandemic. 
Furthermore, a lower proportion of women reported a chronic 
mental illness when compared with the general birthing population. 
Consequently, we cannot exclude the possibility that the more se-
verely depressed or anxious women did not participate in the online 
survey. Hence, it might be possible that the high level of mental dis-
tress observed in our cohort is still an underestimation of the actual 
situation in the general perinatal population. Second, the lack of a 
nonpregnant comparison group and the cross- sectional study design 
generally prevented us from drawing conclusions on the (long- term) 
impact of the pandemic, and whether the observed mental distress 
quickly resolved or persisted for a longer period of time. The pre- 
pandemic mental health status of individual respondents as well as 
the extent of partner support and media usage during the pandemic 
was unknown. Third, women's self- reported symptoms were not 
specific for SARS- CoV- 2 infection, and were therefore not used in 
the analyses to avoid unjustified conclusions. Fourth, only 232 UK 
residents participated; this necessitates careful interpretation of the 
UK findings. Fifth, due to the lack of validated and clinically relevant 
cut- off values, the anxiety and stress scale scores were considered 
as continuous variables in the analysis. Finally, the regression mod-
els only explored associations between mental health status and 
sociodemographic, health, and reproductive characteristics. Future 
studies should investigate which other variables, including the im-
pact of ongoing/severe COVID- 19, affect women's psychological 
well- being.
5  |  CONCLUSION
This cross- sectional study performed across five European countries 
in June- July 2020 found high levels of depressive symptoms and 
generalized anxiety among pregnant and breastfeeding women dur-
ing the COVID- 19 pandemic. Risk factors associated with poor men-
tal health status included a chronic mental illness, a chronic somatic 
illness in the postpartum period, smoking, an unplanned pregnancy, 
professional status, and living in the UK or Ireland. The study find-
ings underline the importance of monitoring perinatal mental health 
during pandemics and other societal crises to safeguard maternal 
and infant mental health.
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